Intra-Cellular Therapies Inc. News
Intra-Cellular Therapies, Watford Holdings: Top Stock Gainers for Wednesday
Intra-Cellular Therapies, Watford Holdings, Trillium Therapies, Vivent Smart Home and DiamondPeak are among top stock gainers for Wednesday.
Intra-Cellular Leaps on Signs of Fewer Side Effects With Schizophrenia Drug
Standard treatments can cause motor side effects and/or weight gain, cardiovascular complications, dyslipidemia, and hyperglycemia.
Intra-Cellular Evades Scrutiny on Schizophrenia Drug Safety, Shares Plunge
Today's Intra-Cellular update was probably going to send the stock price falling regardless of how management acted, but the refusal to be transparent made a bad day even worse.
Biotech Movers: Intra-Cellular Therapies, Organovo, Acorda
Intra-Cellular Therapies, Organovo Holdings and Acorda Therapeutics were among the biotech stock movers in premarket trading on Monday.
Could These 9 Drugs Gain FDA Approval in the Age of Trump?
Nine biotech and drug companies want FDA approval, but need changed standards to get it.
Intra-Cellular Therapies (ITCI) Stock Tanks on Drug Failure, JMP Securities Downgrades
Intra-Cellular Therapies' (ITCI) stock rating was lowered to 'market perform' at JMP Securities on Thursday based on its unsuccessful phase III schizophrenia drug trial.
Surprise: Tesla Has a New Vehicle for the Holidays
EV leader Tesla had indicated in January that it would not introduce a new vehicle to the market in 2022.
Elon Musk Shakes Up USA-Russia Talks Over Brittney Griner
Tesla's billionaire CEO is calling on the Biden administration to make a move against the mass incarceration of people for weed.
Stock Market Today - 8/11: Stocks End Mixed As Cooling Inflation Slows Fed Rate Bets
Stocks finished the day mixed as investors reappraised inflation concerns and the potential impact on interest rates.
Royal Caribbean Follows Norwegian in Making Huge Covid Move
Royal Caribbean cruise line has slowly returned to its prepandemic normal, and Carnival Cruise is likely to follow on soon.